HIGHFDA DRUG

Major Pharmaceuticals Chlorpromazine Hydrochloride 200 mg Recall Involves 1,394 Blister Packs (2025)

Major Pharmaceuticals recalled 1,394 blister packs of Chlorpromazine Hydrochloride Tablets, 200 mg, distributed nationwide. The recall cites CGMP deviations with the presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit. Healthcare providers and patients are urged to stop using the product and await guidance from Major Pharmaceuticals and Rugby Laboratories.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
September 12, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
September 12, 2025
Hazard Level
HIGH
Brands
Chlorpromazine Hydrochloride, Major Pharmaceuticals
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Chlorpromazine Hydrochloride, Major Pharmaceuticals
Product type
Chlorpromazine Hydrochloride Tablets
Model numbers
N01928, N02008, N02071
UPC codes
0904-7129, 0904-7130, 0904-7131, 0904-7132, 0904-7133, 0904-7129-61, 0904-7130-61, 0904-7130-06 +4 more
Sold at
Unknown
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    September 12, 2025

  2. Reported by FDA DRUG

    October 15, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories or your healthcare provider for guidance. Notification method: Letter

About This Product

Chlorpromazine Hydrochloride is an antipsychotic medication prescribed for certain psychiatric conditions. The recalled tablets were distributed nationwide in blister packs across the United States.

Why This Is Dangerous

The recall centers on CGMP deviations due to the presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit detected in the product.

Industry Context

This recall is not described as part of a broader industry pattern in the provided notice.

Real-World Impact

Patients prescribed this drug may be affected if they possess the recalled lots. The immediate action is to stop use and contact the sponsor for guidance.

Practical Guidance

How to identify if yours is affected

  1. Check packaging for NDC 0904-7133-61
  2. Look for the batch or lot number on the blister pack
  3. Verify the product is Chlorpromazine Hydrochloride Tablets, 200 mg, 100-tablet blister packs

What timeline to expect

Refunds or replacements are handled per sponsor recall communications, typically within weeks to a few months following confirmation

If the manufacturer is unresponsive

  • Document all communications with the sponsor
  • File a consumer complaint with FDA if the sponsor is unresponsive
  • Consult a healthcare provider for alternative treatment recommendations

How to prevent similar issues

  • Verify NDC numbers before refilling or accepting medications from distributors
  • Ask pharmacists to confirm CGMP-compliant manufacturing practices
  • Monitor FDA recall updates for any changes to status

Documentation advice

Keep the recall notice, product packaging, and any correspondence with the sponsor. Record dates of purchase and prescription details if available.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Model numbers: N01928, N02008, N02071. Where sold: Nationwide. When sold: Unknown. Price: Unknown. NDC: 0904-7133-61. UPC: 0100309047133611. Quantity recalled: 1,394 blister packs.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • 1394 blister packs recalled nationwide
  • NDC 0904-7133-61 identified on product
  • N-Nitroso Desmethyl Chlorpromazine impurity above intake limit
  • Rx Only, Major Pharmaceuticals distributed via Harvard Drug Group
  • Recall status: ACTIVE as of 2025-10-15

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
POISONING

Product Classification

Product Details

Model Numbers
N01928
N02008
N02071
UPC Codes
0904-7129
0904-7130
0904-7131
+9 more
Affected States
ALL
Report Date
October 15, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls